Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Peptidoglycan D-alanyl-D-alanine terminus is a critical structural component of the bacterial cell wall precursor, specifically found at the C-terminal end of the pentapeptide chain (StatPearls, 2023). This dipeptide motif serves as the substrate for transpeptidase enzymes (penicillin-binding proteins) that catalyze the cross-linking of peptidoglycan layers, providing mechanical strength to the bacterial cell wall (NCBI, 2022). It is the primary molecular target for glycopeptide antibiotics, such as vancomycin and teicoplanin, which bind to the D-Ala-D-Ala moiety via a network of five hydrogen bonds (PubMed, 2021). By sequestering this terminus, these drugs sterically hinder the enzymatic assembly of the cell wall, leading to bacterial cell lysis and death (Nature, 2020). This target is predominantly relevant in Gram-positive bacteria, as the outer membrane of Gram-negative bacteria typically prevents glycopeptide penetration. Resistance to drugs targeting this site often involves the metabolic reprogramming of the cell wall synthesis pathway to replace the terminal D-alanine with D-lactate or D-serine, significantly reducing drug binding affinity (Microbiology Society, 2019).
Glycopeptide antibiotics bind with high affinity to the D-alanyl-D-alanine C-terminus of the peptidoglycan precursor, sterically inhibiting the transglycosylation and transpeptidation reactions required for cell wall cross-linking (StatPearls, 2023; PubMed, 2021).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan D-alanyl-D-alanine terminus (D-Ala-D-Ala) (D-Ala-D-Ala).